Product NDC: | 0781-9164 |
Proprietary Name: | Octreotide Acetate |
Non Proprietary Name: | Octreotide Acetate |
Active Ingredient(s): | 1000 ug/mL & nbsp; Octreotide Acetate |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-9164 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019667 |
Marketing Category: | NDA |
Start Marketing Date: | 19881021 |
Package NDC: | 0781-9164-75 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (0781-9164-75) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 0781-9164-75 |
Proprietary Name | Octreotide Acetate |
Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (0781-9164-75) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 0781-9164 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Octreotide Acetate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 19881021 |
Marketing Category Name | NDA |
Labeler Name | Sandoz Inc |
Substance Name | OCTREOTIDE ACETATE |
Strength Number | 1000 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |